1. Home
  2. INTT vs AVTX Comparison

INTT vs AVTX Comparison

Compare INTT & AVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo inTest Corporation

INTT

inTest Corporation

HOLD

Current Price

$13.99

Market Cap

175.3M

Sector

Technology

ML Signal

HOLD

Logo Avalo Therapeutics Inc.

AVTX

Avalo Therapeutics Inc.

HOLD

Current Price

$17.53

Market Cap

339.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INTT
AVTX
Founded
1981
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
175.3M
339.9M
IPO Year
1997
2015

Fundamental Metrics

Financial Performance
Metric
INTT
AVTX
Price
$13.99
$17.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$13.50
$36.80
AVG Volume (30 Days)
139.5K
805.9K
Earning Date
05-01-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
72.07
EPS
N/A
N/A
Revenue
$66,801,000.00
$27,813,137.00
Revenue This Year
$13.07
N/A
Revenue Next Year
$6.52
N/A
P/E Ratio
N/A
N/A
Revenue Growth
66.06
2312.27
52 Week Low
$5.24
$3.39
52 Week High
$15.66
$20.72

Technical Indicators

Market Signals
Indicator
INTT
AVTX
Relative Strength Index (RSI) 56.82 65.28
Support Level $7.21 $17.18
Resistance Level $15.34 $19.26
Average True Range (ATR) 0.86 1.20
MACD -0.22 0.28
Stochastic Oscillator 45.17 98.63

Price Performance

Historical Comparison
INTT
AVTX

About INTT inTest Corporation

inTest Corp is a supplier of test and process technology solutions for use in manufacturing and testing across a wide range of markets, including Semi, Auto/EV, Defense/Aerospace, Industrial, Life Sciences, Safety/Security, and Other. The Company has three operating segments, which are also its reportable segments and reporting units: Electronic Test, which generates the majority of its revenue and includes semiconductor test equipment, flying probe, and in-circuit testers; Environmental Technologies, which includes thermal test, process, and storage products; and Process Technologies, which includes induction heating and video imaging products. The Company generates the maximum revenue from the U.S.

About AVTX Avalo Therapeutics Inc.

Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).

Share on Social Networks: